A Food and Drug Administration (FDA) advisory committee recommended on Tuesday the COVID-19 injection for children 5 to 11 despite admitting not knowing the long-term risks.

The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted in panel 17-0 to approve a lower dose of the Pfizer's COVID injection for about 28 million American children through emergency use authorization.

The panel convened to answer the following question: "Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 Vaccine when administered as a 2-dose series outweigh its risks for use in children 5-11 years of age?"

Dr. Eric Rubin, one of the voting members, admitted nobody knows the long-term effects of the Covid injection in children, which is why it should be approved.